While using the brand names seems like a trivial issue at the outset, using these
names is inherently problematic. Cardiovascular drugs remain the most commonly prescribed
drugs by the physicians. The junior doctors are likely to introject practices of their
seniors and consequently to reciprocate from the experiences learnt from their preceptors.
Using the generic names may be one way to facilitate prescription of the generic drugs
who have a better cost profile and similar efficacy than the more expensive branded
drugs. In this editorial, we have outlined several arguments to suggest the importance
of using the generic names in academic discussions and clinical documentation.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Brand name statin prescribing ina resident ambulatory practice: implications for teaching cost-conscious medicine.J Grad Med Educ. 2014; 6: 484-488
- Physicians with the least experience have higher cost profiles than do physicians with the most experience.Health Aff. 2012; 31: 2453-2463
- Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.JAMA. 2008; 300: 2514-2526
Centers for Medicare and Medicaid Services, Office of the Actuary, National Health Statistics Group. National health care expenditure projections 2010–2020. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/downloads/proj2010.pdf. Accessed on March 20, 2016.
- The internal medicine reporting milestones and the next accreditation system.Ann Intern Med. 2013 2; 158: 557-559
- “Top 5” lists top $5 billion.Arch Intern Med. 2011; 17: 1856-1858
- Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).Am J Cardiol. 1998; 81: 582-587
- Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.Diabetes Obes Metab. 2005; 7: 430-438
- How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction.Health Serv Res. 2013; 48: 1960-1977
- Patterns and predictors of generic narrow therapeutic index drug use among older adults.J Am Geriatr Soc. 2013; 61: 1586-1591
- Effect of attending practice style on generic medication prescribing by residents in the clinic setting: an cbservational study.J Gen Intern Med. 2015; 30: 1286-1293
Article info
Publication history
Published online: March 19, 2016
Accepted:
March 8,
2016
Received in revised form:
March 8,
2016
Received:
January 16,
2016
Footnotes
See page 1852 for disclosure information.
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
